Sat, May 25, 2013, 8:55 AM EDT - U.S. Markets closed
TTNP is only $1.89.
It's product will revolutionize the treatment of addiction.
Millions are addicted to pain meds and illicit drugs.
TTNP received FDA priority review for its 6 month slow release abuse proof implant.
Its ProNeura technology is also being advanced for chronic pain and Parkinsons.
In April, upon approval, TTNP will receive a $50,000,000 milestone payment plus future double digit royalties.